DNM1L and osteosarcoma: illustrated that inhibiting mitochondrial fragmentation through blocking dynamin-related protein 1 (DRP1), a key promoter of fission, improved the osteogenic differentiation of human osteosarcoma cell line exposed to oxidative stress.24